Literature DB >> 19780654

Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators.

Kathleen M Knights1, John O Miners.   

Abstract

The role of the kidney in drug and chemical disposition has traditionally focused on the excretion of polar xenobiotics and metabolites. However, there is increasing evidence demonstrating that renal UGTs are integral to the "local" intrarenal, and, possibly, systemic, metabolic clearance of numerous drugs and nondrug xenobiotics, as well as to the maintenance of renal homeostasis through limiting the biological activity of endogenous renal mediators that control electrolyte balance and renal blood flow. The common involvement of UGT1A9 and UGT2B7 in the metabolism of both endogenous and exogenous compounds in kidney predicates significant renal drug-endobiotic interactions that may explain, in part, the adverse renal effects of some drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19780654     DOI: 10.3109/03602530903208561

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  6 in total

1.  Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis.

Authors:  Melanie S Joy; Tammy Boyette; Yichun Hu; Jinzhao Wang; Mary La; Susan L Hogan; Paul W Stewart; Ronald J Falk; Mary Anne Dooley; Philip C Smith
Journal:  Eur J Clin Pharmacol       Date:  2010-06-22       Impact factor: 2.953

2.  Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues.

Authors:  Guillaume Margaillan; Michèle Rouleau; John K Fallon; Patrick Caron; Lyne Villeneuve; Véronique Turcotte; Philip C Smith; Melanie S Joy; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2015-02-03       Impact factor: 3.922

3.  Enantiomer selective glucuronidation of the non-steroidal pure anti-androgen bicalutamide by human liver and kidney: role of the human UDP-glucuronosyltransferase (UGT)1A9 enzyme.

Authors:  Laurent Grosse; Anne-Sophie Campeau; Sarah Caron; Frédéric-Alexandre Morin; Kim Meunier; Jocelyn Trottier; Patrick Caron; Mélanie Verreault; Olivier Barbier
Journal:  Basic Clin Pharmacol Toxicol       Date:  2013-05-20       Impact factor: 4.080

4.  Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance.

Authors:  Kathleen M Knights; Shane M Spencer; John K Fallon; Nuy Chau; Philip C Smith; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2016-03-14       Impact factor: 4.335

5.  Regioselective glucuronidation of andrographolide and its major derivatives: metabolite identification, isozyme contribution, and species differences.

Authors:  Xiangge Tian; Sicheng Liang; Chao Wang; Baojian Wu; Guangbo Ge; Sa Deng; Kexin Liu; Ling Yang; Xiaochi Ma
Journal:  AAPS J       Date:  2014-09-10       Impact factor: 4.009

6.  Metabolism of Long-Acting Rilpivirine After Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076).

Authors:  Herana Kamal Seneviratne; Joseph Tillotson; Julie M Lade; Linda-Gail Bekker; Sue Li; Subash Pathak; Jessica Justman; Nyaradzo Mgodi; Shobha Swaminathan; Nirupama Sista; Jennifer Farrior; Paul Richardson; Craig W Hendrix; Namandje N Bumpus
Journal:  AIDS Res Hum Retroviruses       Date:  2021-01-13       Impact factor: 2.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.